CERS
CERUS CORP
Nasdaq Surgical & Medical Instruments & Apparatus Accelerated filer

Key Financials

Gross Profit
$16.9M
↑ 273.6%
Net Income
$-15627000
↑ 25.3%
Revenue
$233.8M
↑ 16.1%
EPS (Diluted)
$-0.08
↑ 27.3%
Total Liabilities
$156.9M
↑ 8.9%
Operating Income
$-8681000
↑ 39.0%
Shareholders' Equity
$64.2M
↑ 14.4%
Long-term Debt
$20.0M
↑ 100.0%

Recent SEC Filings

Form Type Filed Date Link
4 4/3/2026 View on SEC
4 4/3/2026 View on SEC
SCHEDULE 13G/A 3/26/2026 View on SEC
SCHEDULE 13G 3/24/2026 View on SEC
4 3/16/2026 View on SEC
4 3/16/2026 View on SEC
4 3/16/2026 View on SEC
4 3/16/2026 View on SEC
4 3/16/2026 View on SEC
8-K 3/16/2026 View on SEC

Company Information

Field Value
Ticker CERS
Company Name CERUS CORP
CIK 1020214
Sector Surgical & Medical Instruments & Apparatus
Industry Accelerated filer
Exchange Nasdaq
SIC Code 3841
SIC Description Surgical & Medical Instruments & Apparatus
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 9252886000